Search
Search Constraints
You searched for: Author/Creator Slifka, Mark K.Limit your search
- Slifka, Mark K. [remove] 7
- Vaccines -- Periodicals 4
- 615.372 3
- 571.96 1
- 615.37205 1
- 616.15 1
- 617.95 1
- AEI acetyl-ethyleneimine -- BPL β-propiolactone -- cGMP current good manufacturing practices -- Env envelope protein -- FMDV foot-and-mouth disease virus -- FIMV formaldehyde-inactivated measles virus -- FIRSV formaldehyde-inactivated respiratory syncytial virus -- GMT geometric mean NT50 titer -- HA hemagglutinin -- H2O2 hydrogen peroxide -- IACUC institutional animal care and use committee -- i.p. intraperitoneal -- MZ methisazone -- MAb monoclonal antibody -- NT50 50% neutralizing titer -- NHP non-human primates -- T1/2 half-life -- TFF tangential flow filtration -- UV ultraviolet -- WNV West Nile virus -- WNV-KV WNV Kunjin strain -- YFV yellow fever virus 1
- BDS bulk drug substance -- BPL β-propiolactone -- cGMP current good manufacturing practices -- DENV dengue virus -- DP drug product -- Env envelope protein -- FFA focus forming assay -- GLP good laboratory practices -- H2O2 hydrogen peroxide -- IVRP in vitro relative potency -- JEV Japanese encephalitis virus -- LOD limit of detection -- MAb monoclonal antibody -- MCB master cell bank -- MOI multiplicity of infection -- MVB master virus bank -- NT50 50% neutralizing titer -- PFU plaque forming unit -- PPV porcine parvovirus -- pre-MVB pre-master virus bank -- s.c. subcutaneous -- T1/2 half-life -- TPP triple plaque purification -- WCB working cell bank -- WNV West Nile virus -- WNV-KV WNV Kunjin strain -- WVB working virus bank -- YFV yellow fever virus 1
- Blood -- Diseases 1
- Blood -- Diseases -- Periodicals 1